Major advantages of using aequorin
Selective intracellular distribution. The main reason for the renewed interest in using aequorin is that, being a protein, it can be engineered to induce its specific localization to a cell region of interest 10, 11 . Although wild-type aequorin is exclusively cytosolic (cytAEQ), the addition of specific targeting sequences permits selective localization of the photoprotein, resulting in recombinant aequorin chimeras for different intracellular compartments: nucleus (nuAEQ), mitochondria (mtAEQ and mimsAEQ),
• subplasma-membrane cytosol (pmAEQ), endoplasmic/ sarcoplasmic reticulum (erAEQ/srAEQ), Golgi apparatus (goAEQ), secretory vesicles (vampAEQ) and peroxisomes (peroxAEQ). Details of the construction of the different chimeras are described in Table 2 . In all cases, the correct intracellular localization of the different probe has been verified through immunofluorescence localization with antibodies against the aequorin protein or the epitope added to its sequence and using specific markers for the different intracellular compartments. Nucleus NuAEQ A fragment of rat glucocorticoid receptor, lacking the hormone-binding domain and the nuclear localization signal are fused with the HA1-tagged aequorin 31 MtAEQwt Mitochondrial pre-sequence of subunit VIII of cytocrome c oxidase (COX) is fused to the HA1-tagged aequorin, for measurements of [Ca 2+ ] up to 10-15 µM (ref. 32) Mitochondrial matrix mtAEQmut The mutated version of mtAEQwt. Because of the cooperativity between the three Ca 2+ -binding sites of aequorin, the point mutation (Asp119Ala) 13 that affects the second EF-hand domain, produces a mutated aequorin, which can be used to measure [Ca 2+ ] in the range of 10-500 µM (ref. 33) mtAEQmut28,119 Double-mutated form (Asp119Ala and Asn28Leu) of mtAEQwt, which can be used to measure [Ca 2+ ] in the millimolar range for long periods of time, without problems derived from aequorin consumption 14 Mitochondrial intermembrane space MimsAEQ HA1-tagged aequorin is fused (sequence in frame) with glycerol phosphate dehydrogenase, an integral protein of the inner mitochondrial membrane, with a large C-terminal tail protruding on the outer side of the membrane, i.e., in the mitochondrial intermembrane space 34 Plasma membrane pmAEQ The targeting of aequorin to the subplasmalemmal space was based on the construction of a fusion protein including the HA1-tagged aequorin and SNAP-25, a protein that is synthesized on free ribosomes and recruited to the inner surface of the plasma membrane after the palmitoylation of specific cysteine residues 35 Endoplasmic reticulum erAEQmut The encoded polypeptide includes the leader sequence (L), the VDJ and CH1 domains of an Igg2b heavy chain (HC) and the HA1-tagged aequorin at the C-terminus. In this chimera, retention in the ER depends on the presence of the CH1 domain at the N terminus of aequorin. This domain is known to interact with the luminal ER protein BiP, thus causing the retention of the Igg2b HC in the lumen. In the absence of the immunoglobulin light chain, the polypeptide is retained in this compartment 36 Sarcoplasmic reticulum srAEQmut Calsequestrin (CSQ), a resident protein of the sarcoplasmic reticulum, is fused to HA1-tagged aequorin. This chimera is used to measure [Ca 2+ ] in the sarcoplasmic reticulum, the specialized muscle compartment involved in the regulation of Ca 2+ homeostasis 37 Golgi apparatus goAEQmut Fusion of the HA1-tagged aequorin and the transmembrane portion of sialyltransferase, a resident protein of the Golgi lumen 18 Secretory vescicles vampAEQmut Mutated AEQ (AEQmut; Asp119Ala) is fused to the vesicle-associated membrane protein (vamp)2/synaptobrevin (a vesicle-specific SNARE with a single transmembrane-spanning region) allowing intravesicular [Ca 2+ ] to be monitored 38
Wide dynamic range. Native aequorin and its mutants ( response curve of aequorin, if the probe is distributed between a high-Ca 2+ and a low-Ca 2+ domain, the former will undergo a much larger discharge. The total signal will be calibrated as 'average' [Ca 2+ ] increase, which will be severely biased by the region with high Ca 2+ . Cells must be amenable to transfection. The obvious requirement of this approach is that the cell type being studied must be amenable to transfection (Box 2).
Experimental design
The proposed protocol allows measurement of Ca 2+ signaling in a wide variety of cell types in different subcellular compartments.
Owing to the variety of [Ca 2+ ] in different subcellular compartments, different combinations of aequorin and coelenterazine, with modified sensitivity, have been developed. A general overview of the protocol could be summarized in a few points (represented in Fig. 1 ): cell transfection, aequorin reconstitution, light recording during Ca 2+ homeostasis perturbation and light recording during cell lysis induction (with consequent measurement of the total aequorin amount). The first and fundamental issue to be defined is the choice of readout. Different aequorin chimeras have been proposed, depending on the intracellular localization of the [Ca 2+ ] to be investigated ( Table 2 ). An appropriate aequorin-coelenterazine combination is also required. A general guideline could be as follows: native aequorin with native coelenterazine for [Ca 2+ ] from 0.1 µM to 10 µM; aequorin(Asp119Ala) with native coelenterazine In addition to native coelenterazine, other derivates have been produced: these coelenterazines are designed as cp, f, h, hcp, n and i. These variants conserve the characteristics required to be used to reconstitute the aequorin complex both in vivo and in vitro, and the reconstituted photoprotein exhibits markedly changed luminescence quantum yield and response speed to Ca 2 + binding. Coelenterazine n and i display reduced light emission, as low as 3% of the native coelenterazine, and a slower response to Ca 2 + binding 12 . Development of coelenterazine with reduced light emission was necessary for proper increase of the dynamic range in the plethora of aequorin-based Ca 2 + assays. Different intracellular compartments display [Ca 2 + ] above the dynamic range of native aequorin or even the low-affinity aequorin mutant Asp119Ala. Introduction of coelenterazine n and i allowed the reduction of aequorin affinity, to an affinity that was low enough to perform measurements in very high [Ca 2 + ], such as in the ER, Golgi apparatus or mitochondria (table 2) .
On the opposite extreme, it has been demonstrated that aequorins reconstituted with coelenterazine derivates cp, f, hcp or h display relative intensities that are higher (10-20 times more potent), as compared with apoaequorin containing the native coelenterazine. Of crucial interest is the h variant, as it has been shown that aequorin prepared with this derivate was more sensitive (compared with aequorin reconstituted with native coelenterazine), thus delivering a new tool for measuring small changes in Ca 2 + concentrations 39 .
Furthermore, the increase of emitted light made the new coelenterazine h suitable for assays that suffer in sensitivity or that require small populations of cells, thus allowing the development of a series of assays for luminescence high-throughput screening.
It should be taken into consideration that until now no calibration curve has been developed for the combined use of native aequorin with the high-sensitivity coelenterazine derivatives (cp, f, hcp and h); therefore, absolute [Ca 2 + ] (with the mean of molar values) is impossible to determine and it is possible to describe only relative concentrations (often expressed in arbitrary luminescence units).
for [Ca 2+ ] from 10 µM to 100 µM; and aequorin(Asp119Ala) with coelenterazine n for [Ca 2+ ] from 100 µM to 1,000 µM. Once the proper combination has been chosen, the researcher has to set up its proper expression protocol. Several transfection methods have been successfully used to drive expression of aequorin.
The central event in the measurement protocol is the perturbation of Ca 2+ resting conditions, with the generation of changes in intracellular [Ca 2+ ]. The perturbing agent has to be chosen considering two different concepts: first, the source of Ca 2+ (intracellular stores such as the ER or the extracellular medium); and second, the cell type, because receptors capable of activating Ca 2+ waves could differ in type and expression, depending on the cell model. Examples of the most commonly used Ca 2+ -perturbing agents used for aequorin assays are listed in Table 3 .
To optimize the assay, several controls should be performed. A positive control for probe expression is provided by cell lysis, which is done as the final phase of each procedure. Light emission induced upon cell lysis is directly proportional to the whole amount of aequorin expression. A useful negative control is to perform the preferred reconstitution and recording
Box 2 | Cell preparation and transfection • tIMInG 3 h
We have used a wide variety of cell types (e.g., HeLa, HEK 293T, CHO, COS-7, SH-SY5Y, A7r5, PC12, MEF as well as primary cultures of neurons and skeletal muscle myotubes), with good results in terms of aequorin expression using the appropriate transfection methods. It is not the purpose of this paper to describe all possible transfection procedures, the choice of which depends mainly on the cell type being studied. The Ca 2+ phosphate procedure is by far the simplest and least expensive and has been used successfully to transfect a number of cell lines, including HeLa, HEK 293T, L929, L, COS-7, A7r5, PC12 cells and myotubes. Other transfection procedures have also been employed, such as liposomes, polyethylenimine and electroporation; viral constructs for some aequorins are also available [40] [41] [42] . 1. Cell growth. Seed cells onto circular glass coverslips (diameter, 13 mm) for single-sample luminescence measurements. For platereader analysis, seed cells directly into the preferred multiwell type; avoid the use of coverslips. Allow cells to grow until ~50% confluence; optimize plating densities for each specific cell line.  pause poInt After seeding cells, wait at least 24 h. 2. Transfection. When the cells have reached 40-60% confluence, transfect them with 1-2 µg of vector encoding aequorin per coverslip, depending on the desired transfection method (usually 1 µg cm −2 for liposomes or polyethylenimine and 2 µg cm −2 for Ca 2+ phosphate).
Choose the appropriate transfection reagent and optimized protocol for the particular cell line being used. Alternatively, create a stable cell line using standard protocols 15 .  pause poInt After transfection, wait 36-48 h. Signal recording procedure in nontransfected cells. Further, the buffering effect of aequorin could be easily verified by performing Fura-2 experiments in cells expressing reconstituted aequorin and in cells expressing empty vector as described by Brini et al. 15 .
Finally, if new compounds need to be used, it is important to verify whether the compounds themselves condition the aequorin activity. To check this aspect, we recommend the following control experiment. Reconstituted aequorin must be 
Box 3 | Cell population analysis with plate reader • tIMInG 3-6 h
The low complexity of protocols for cytoplasmic and mitochondrial [Ca 2+ ] and [Ca 2+ ] measurements with aequorin allows easy automation of the process and development of assays for plate readers. This, in addition to development of high-sensitivity coelenterazines (box 1), permits the development of high-throughput screening. One of these platforms (called Aequoscreen) is based on the expression of apoaequorin in cells that also express the superfamily of G protein-coupled receptors. This cellular aequorin-based functional assay was adapted for high-throughput screening, and it has been reported to have good reproducibility, high signal and high throughput (100,000 compounds per day) 43 . Another platform based on aequorin is the LumiLux (PerkinElmer), which in 2008 was also validated for calcium measurements assays by high-throughput screening. This instrument is reported to allow ultrahigh-throughput cellular imaging (up to 1,536-well microplates) 44 . The final goal of these 'aequorin-based luminescence platforms' is to generate superior-quality screening data of calcium measurements, with automated image acquisition and data analysis, allowing explorative screening and the identification of new drugs by screening tens of thousands of molecules. Beyond drug discovery, the high-content technology could provide useful tools for learning where and when a subset of proteins act or for identifying genes involved in several mechanisms, for example, cell division, cancer and neurodegeneration.
Plate readers based on the aequorin assay could in any case be used in the range of medium to low throughput for exploring Ca 2+ signals in suspended cell populations, using wild-type coelenterazine.
Here we describe a quick and easy protocol for an aequorin assay with plate readers.
additional materials Ca 2+ -mobilizing solution, 3× (3× CMS).
Dissolve the Ca 2+ -perturbing agent in modified KRB; different cell types require different agents.
The most common agents are listed in table 3. Freshly prepare the solution, and do not store it. Lysis solution, 4×, 0.4% Triton X-100. Add 0.4 ml of Triton X-100 and 1 ml of 1 M CaCl 2 to 100 ml of Milli-Q water. This solution can be stored at 4 °C for 1 month. Luminescence plate reader. Different plate readers are available on the market. These are usually designed to allow maximum sensitivity. Nonetheless, the reading protocol should be optimized for aequorin 45 . In particular, no emission filters should be placed between the sample and the photomultiplier. Reading has to occur from the bottom of the plate, to allow reading during injection of stimuli. Liquid injection in the well has to be optimized to allow both a rapid diffusion of the stimulus, while avoiding cell detachment (two injectors are required; examples include VITOR3 or Microbeta Jet from PerkinElmer). Readers with multiple reading positions are available and should be chosen to avoid having cell samples remain in a non-optimized environment for too long; alternatively, readers with a temperature-controlled environment are also available.
(continued)
extracted from cells in the absence of Ca 2+ and in the presence or absence of the compound to be tested. Finally, Ca 2+ must be added, and the luminescence must be monitored. If the same amount of light is emitted in both conditions, then the compound should not affect aequorin activity and could be safely used.
For adherent cells, we provide several protocols for aequorin measurements through the use of perfusion chamber-based single-tube luminometers. Furthermore, we provide a protocol based on automated plate reader luminometers, which allows for measurements of suspended cells, also in high-throughput assays (Box 3 and Fig. 2) . Given the choice to use plate readers, a few concepts must be considered during the experimental setup. For plate reader-based assays, we recommend avoiding the use of erAEQ, srAEQ and goAEQ because of the higher complexity of the measurement protocol. Conversely, cytoplasmic or mitochondrial aequorin displays a substantially less complexity, making them suitable for automation. In our experience, plate-reader luminometers display a reduced sensitivity when compared with single-tube photomultipliers, especially when 96-well plates are used. In this case, if the cell system chosen has a low-expression yield, we suggest the use of high-sensitivity coelenterazine derivatives (Box 1) rather than wild-type coelenterazine. It should be noted, however, that for most of these coelenterazine derivatives a calibration curve is still not available (Box 1). Modified KRB Prepare modified KRB by adding 0.5 ml of 1 M CaCl 2 to 500 ml of KRB. This solution can be stored at 4 °C for 3 d.  crItIcal This solution should be prepared in a polypropylene cylinder; glass containers could bind Ca 2+ , giving rise to experimental imprecisions. Coelenterazine solution, 100× Although coelenterazine is relatively stable when stored undissolved at −80 °C, it is extremely labile once dissolved. Coelenterazine is usually dissolved at 0.5 mM in pure methanol as a 100× stock solution kept at −20 °C for short periods (few days) or −80 °C for longer periods. We recommend that the supply of coelenterazine solution be split into small aliquots (~50 µl) and kept protected from light.  crItIcal Methanol evaporates extremely fast, so we recommend sealing the aliquots with Parafilm and keeping them on ice during handling.
Box 3 | (continued)
• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •
Ca 2+ -mobilizing solution (CMS)
Dissolve the Ca 2+ -perturbing agent in modified KRB; different cell types require different agents. The most common agents are listed in Table 3 . Freshly prepare the CMS, and do not store it. Ionomycin, 1 mM stock solution Prepare 1 mM ionomycin stock solution by dissolving 1 mg of ionomycin in 1.34 ml of DMSO and divide the stock solution into aliquots. This solution can be stored at −20 °C for 6 months.  crItIcal Avoid multiple freeze-thaw cycles. tBHQ, 100 mM solution Prepare 100 mM tBHQ solution by dissolving 166 mg of tBHQ in 10 ml of DMSO, and divide the solution into aliquots. This solution can be stored at −20 °C for 6 months. Lysis solution, 0.1% Triton X-100 Prepare lysis solution by adding 0.1 ml of Triton X-100 and 1 ml of 1 M CaCl 2 to 100 ml of Milli-Q water. This solution can be stored at 4 °C for up to 1 month. EGTA, 0.5 M stock solution Prepare EGTA stock solution by dissolving 19.01 g of EGTA in 100 ml of Milli-Q water. Use NaOH to help dissolving the solution, and then adjust the pH of the solution with HCl to 7.4. This solution can be stored at room temperature (22-30 °C) for 2 months. Ca-free buffer (CFB) Prepare Ca-free buffer by adding 0.06 ml of EGTA stock solution to 300 ml of KRB (required only for erAEQ, goAEQ, srAEQ and pmAEQ). Freshly prepare the buffer, and do not store it. 2 Prepare modified IB by dissolving 1 g of glucose, 0.0886 g of pyruvic acid and 0.609 g of MgCl 2 in 100 ml of 10× IB. Add 4 ml of 0.5 M KEGTA and 4 ml of 0.5 M EDTA to it. Adjust the volume to 800 ml with Milli-Q water and adjust solution pH to 7 with KOH. Finally, adjust the final volume to 1,000 ml with Milli-Q water. Freshly prepare the solution, and do not store it. ATP intracellular buffer (AIB) Prepare AIB by dissolving 0.275 g of ATP in 500 ml of modified IB. Adjust the pH of the buffer to 7. Freshly prepare the buffer, and do not store it.  crItIcal After the addition of CaCl 2 , check the pH (should be pH 7.0).  crItIcal Store this solution on ice and use only a small amount (~30 ml) at 37 °C during the experiment, to avoid ATP degradation. Permeabilization IB, 25 mM digitonin Prepare permeabilization IB by dissolving 3 mg of digitonin in 100 ml of IB. Freshly prepare the solution, and do not store it. Cell preparation and transfection See Box 2 for details on preparation of cells and transfection of vectors encoding aequorin and aequorin mutants. EQUIPMENT SETUP Luminescence reader: for cell population analysis See Box 4 for details on luminescence reader (aequorinometer). proceDure reconstitution • tIMInG ~60-120 min 1| Depending on intracellular localization, aequorin will be exposed to different intracellular [Ca 2+ ]. As the functional aequorin-coelenterazine probe is irreversibly destroyed by Ca 2+ ions, as reported before, different reconstitution procedures must be followed depending on the aequorin chimera used and the type of experiment (see Fig. 1a to decide which option to use).
In particular, when the recombinant protein is located in a compartment that has high [Ca 2+ ], reconstitution with coelenterazine is highly inefficient because of competition between consumption and reconstitution. To obtain reliable quantitative estimates of [Ca 2+ 
Box 4 | Aequorinometer description
Photons emitted during the experimental procedure can be recorded and analyzed using relatively inexpensive equipment; we refer interested readers to refs. 9 and 46-49 for excellent detailed technical descriptions. In brief, in this system the perfusion chamber, on top of a hollow cylinder, temperature-controlled by a water jacket, is continuously perfused with buffer via a peristaltic pump. The coverslip with cells is placed a few millimeters from the surface of a low-noise PMT. The photon counts are then transferred to a computer for further analysis (Fig. 1) The aequorinometer is composed of an upper part containing a low-noise photomultiplier inserted into a dark box housing a manual shutter (to protect it from light exposure) and a removable temperature-controlled chamber to hold the sample. During aequorin experiments, the shutter is opened, and the perfusion chamber (13 mm diameter, 2 mm height, volume 265 µl) is placed in close proximity ( < 3 mm) of the photomultiplier. The perfusion chamber can house a 13-mm coverslip with adherent cells and is sealed on the top with a coverslip using a thin layer of silicon. Cells are continuously perfused with temperature-controlled medium (water bath, GT-80/P) at 37 °C. A peristaltic pump allows liquid perfusion. The output of the amplifier discriminators is captured by the photon counter C8855-01 connected via a USB cable to a workstation and recorded by the sample software (Hamamatsu Photonics) for storage and further analysis.  crItIcal Before and after each experiment, the plastic tubes must be extensively washed with Milli-Q water. Ensure that both the tubes and the perfusion chamber contain appropriate buffer when the coverslip is placed inside.
 crItIcal No air bubbles should be present in the perfusion chamber, and it must be carefully sealed to avoid buffer leakage.  crItIcal All the systems must be at 37 °C before starting the experiment to ensure proper calibration.  crItIcal After each experiment, remove the 13-mm coverslip from the chamber, reseal the chamber and wash the entire the system extensively by perfusing it with Milli-Q water, thus avoiding spurious signals in the subsequent experiment.  crItIcal Stop the perfusion before changing each medium to avoid generating air bubbles.
2|
As in the reconstitution step, this phase must also be adapted to the aequorin chimera and the intracellular compartment being studied. Choose from options A to F (Fig. 1a) . to obtain a stable signal, and then note the lower value as background. ? troublesHootInG (v) To activate Ca 2+ pathways, pause perfusion and change from modified KRB to CMS. Resume the perfusion and raise its rate from 2.5 to 5 ml min −1 to allow rapid equilibration of the compounds in the perfusion chamber. After addition of agonist, light emission (c.p.s. values) rapidly increases, reaches a peak and then starts to decline (at this point, lower the perfusion rate to the original value). In the case of mtAEQ or mtAEQmut, the c.p.s. value will return to almost basal values within 2 min, whereas with cytAEQ, nuAEQ and mimsAEQ there is a sustained increase of the c. • tIMInG
Step 1: 90-120 min for options A, D, E and F; 50 min for options B and C Step 2: 1.5-2 min for options A, D and E; 3-4 min for option F; 5-8 min for options B and C (for a single sample) Steps 3 and 4: 2 min (for a single sample) Steps 5-8: 5-10 min (for a single sample) box 2, step 1: 30-60 min (depending on cell type); step 2: 30 min-2 h (depending on the transfection method) box 3, steps 1-3: 90-120 min box 3, steps 4-7: 2-3 min box 3, step 8: 50-80 min for 24-well plates; 200-240 min for 96-well plates antIcIpateD results As described in the PROCEDURE, at the end of each experiment, the cells are lysed by perfusing them with a hyposmotic medium containing 10 mM CaCl 2 and a detergent (Triton X-100) to discharge all the aequorin that was not consumed during the experiment; this provides an estimation of the total aequorin content, which must be known to convert the luminescence data into [Ca 2+ ] values.
To transform luminescence values into [Ca 2+ ] values, we used essentially the method described by Allen and Blinks 9 , which relies on the relationship between [Ca 2+ ] and L/L max : L is the light intensity at a given moment and L max is that which would have been recorded if, at that same moment, all the aequorin present in the cell had been suddenly exposed to a saturating [Ca 2+ ]. The rate constant of aequorin consumption at saturating [Ca 2+ ] is 1.0 s −1 , and a good estimate of L max can be obtained by estimating the total aequorin content by discharging all the aequorin content at the end of the experiment (by adding an excess of Ca 2+ and detergents) and collecting the total amount of aequorin light output.
As aequorin is consumed continuously, the value of L max is not constant during the experiment. The value of L max to be used for calculating [Ca 2+ ] at every point along the experiment should be calculated as the total light output in the whole experiment minus the light output recorded before that point. The relationship between the ratio L/L max and [Ca 2+ ] has been modeled mathematically; all calibration curves using native aequorin, mutant aequorins and different forms of coelenterazine have been comprehensively represented by the group of Alvarez 14 and summarized in Figure 3 and table 6 .
Various physiological parameters may affect the Ca 2+ sensitivity of aequorin, such as the [Mg 2+ ] (which decreases the sensitivity of aequorin and thus must be known in order to obtain an accurate [Ca 2+ ] estimate in the cell and/or compartment of interest), the ionic strength and pH (although the effect of this parameter is very modest in the physiological range, i.e., 6.6-7.4). For physiological conditions of pH, temperature and ionic strength, a second to third power relationship between the rate of consumption and the −log[Ca 2+ ] (pCa 2+ ) can be observed in the pCa 2+ range of 5-7; the presence of three Ca 2+ -binding sites in the aequorin molecule is responsible for the high degree of cooperativeness and for the steep relationship between photon-emission rate and [Ca 2+ ].
In Figure 4 , we report all calibrated aequorin traces discussed above; Ca 2+ values of distinct subcellular compartments are typical of HeLa cells. Different cell lines have different intraorganelle [Ca 2+ ] (i.e., the mitochondrial Ca 2+ response in HeLa cells is ~100 µM, whereas in HEK 293 cells it is ~3 µM).
When an experiment is properly set up, Ca 2+ mobilization induces a large signal increase above background. Such an increase is shaped as a peak in cytoplasm, mitochondria, subplasmalemma and peroxisomes, which is rapidly extinguished in ~60 s. In compartments with high [Ca 2+ ] (endoplasmic/sarcoplasmic reticulum and Golgi apparatus), when the [Ca 2+ ] in the perfusion medium is switched to 1 mM CaCl 2 , the [Ca 2+ ] in the lumen of the two compartments gradually increases, reaching a plateau generally in 120-180 s. This plateau is stable for some minutes, during which it can be challenged with agonists (e.g., histamine) to induce Ca 2+ release from intracellular Ca 2+ stores. coMpetInG FInancIal Interests The authors declare no competing financial interests.
